investorscraft@gmail.com

Intrinsic Value of Globe Life Inc. (GL)

Previous Close$118.13
Intrinsic Value
Upside potential
Previous Close
$118.13

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Globe Life Inc. operates as a life and supplemental health insurance provider, primarily serving middle-income families in the United States. The company generates revenue through premiums from its diversified portfolio of life, accident, and health insurance products, distributed via direct-to-consumer and agency-based channels. Globe Life maintains a strong market position by focusing on underserved segments, leveraging cost-efficient underwriting, and maintaining high policy persistency rates. Its competitive edge lies in its targeted marketing strategies and disciplined risk management, which have enabled steady growth in a mature industry. The company operates in a highly regulated environment but benefits from stable demand for its core products, supported by demographic trends and consumer need for financial protection. Globe Life’s ability to maintain low lapse rates and efficient claims processing further solidifies its reputation as a reliable insurer in its niche.

Revenue Profitability And Efficiency

Globe Life reported revenue of $5.78 billion for FY 2024, with net income reaching $1.07 billion, reflecting a robust net margin of approximately 18.5%. Diluted EPS stood at $12.63, demonstrating strong earnings power. Operating cash flow was $1.40 billion, significantly exceeding capital expenditures of $71 million, indicating efficient cash generation. The company’s high profitability is driven by disciplined underwriting and low operational overhead.

Earnings Power And Capital Efficiency

The company’s earnings power is underscored by its consistent ability to convert premiums into profits, with a return on equity likely in the mid-teens given its net income and equity base. Globe Life’s capital efficiency is evident in its ability to fund growth and dividends while maintaining a conservative leverage profile. Its operating cash flow coverage of dividends and buybacks remains strong.

Balance Sheet And Financial Health

Globe Life’s balance sheet shows $165 million in cash and equivalents against total debt of $2.74 billion, reflecting a manageable leverage ratio. The company’s debt is primarily long-term, with no near-term liquidity concerns. Its financial health is further supported by stable insurance reserves and a solid equity base, ensuring resilience against underwriting volatility.

Growth Trends And Dividend Policy

Globe Life has demonstrated steady premium growth, supported by its focus on middle-market consumers. The company pays a dividend of $1.02 per share, with a payout ratio below 10% of net income, allowing for reinvestment and potential increases. Share buybacks have also been a tool for capital return, though the focus remains on organic growth and maintaining underwriting discipline.

Valuation And Market Expectations

The market values Globe Life at a premium relative to peers, reflecting its consistent profitability and low-risk profile. Investors likely price in stable earnings growth, given the company’s niche focus and efficient operations. The current P/E ratio, based on diluted EPS, suggests confidence in sustained performance.

Strategic Advantages And Outlook

Globe Life’s strategic advantages include its targeted market approach, cost-efficient distribution, and strong policy retention. The outlook remains positive, with demographic trends supporting demand for life and supplemental health products. Regulatory risks persist, but the company’s conservative underwriting and capital management position it well for long-term stability.

Sources

Company filings (10-K), investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount